Leadership in clinical trials for pancreatic cancer treatment
Official title: National and Institutional Leadership and Support of NCI-Sponsored Clinical Trial Research as a Surgical Oncologist
Funded at Northwestern University at Chicago · NIH-10974246 · Data updated 2026-11-12
This study is all about creating new and better treatment options for pancreatic cancer, and it invites patients to join exciting clinical trials that could help improve their care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | September 16, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $90,538 |
| NIH project number | 1R50CA293523-01 |
| Project ID | NIH-10974246 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals diagnosed with pancreatic cancer who are seeking access to cutting-edge clinical trials.
✕Less likely to help
Patients with cancers other than pancreatic cancer may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing the clinical trials program for pancreatic cancer at Northwestern University. Led by Dr. Akhil Chawla, the project aims to develop and implement innovative trials that could change current treatment practices. The approach involves collaboration with experts and rigorous protocol development to ensure high-quality research outcomes. Patients may have the opportunity to participate in groundbreaking trials that could lead to improved therapies for pancreatic cancer.
Why it matters
Potential benefit: If successful, this research could lead to new and more effective treatment options for patients with pancreatic cancer.
How similar studies have gone: Previous research in similar clinical trial frameworks has shown promise in improving treatment outcomes for cancer patients.
Where this research is happening
-
Northwestern University at Chicago
Chicago, United States Active
Researchers
- Principal investigator: Chawla, Akhil — Northwestern University at Chicago
- Study coordinator: Chawla, Akhil
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.